April 2026
Create an account to continue using Similarweb
View website metrics, keywords, top marketing channels, market research tools, and more.
Create your free accountgvn.org
Global Rank
#858,993
268,851Showing Similarweb estimated data.
Publicly validate your site’s metrics by connecting your GA4
Reflect your success
Verify your website's traffic and engagement metrics by connecting to Google Analytics
Bounce Rate
35.71%
Pages per Visit
3.52
Avg Visit Duration
00:01:42
- Company
- - -
- Industry
- - -
Top 10 gvn.org Competitors
The Top 10 Sites Like gvn.org in April 2026 are ranked by their affinity to gvn.org in terms of keyword traffic, audience targeting, and market overlap
Background Coinfections of influenza A virus (IAV) and herpes simplex virus type 1 (HSV-1) have been increasingly reported in patients with severe pneumonia, yet their pathogenesis remains poorly understood. Methods We established murine models to investigate the effects of coinfection with HSV-1 (strain KOS) and IAV (A/Aichi/2/1968 (H3N2)) under different orders of infection. Mice were assigned to one of five groups: (1) HSV-1 monoinfection, (2) H3N2 monoinfection, (3) simultaneous coinfection (H3N2 + HSV-1), (4) sequential coinfection with H3N2 administered three days prior to HSV-1 (H3N2-HSV-1), and (5) sequential coinfection with HSV-1 administered three days prior to H3N2 (HSV-1-H3N2). We then compared disease severity, viral replication, lung injury, cytokine profiles along with innate and adaptive immune responses. Results Overall, all coinfection groups developed more severe disease than HSV-1 monoinfection. However, when compared to H3N2 monoinfection, the order of coinfection resulted in distinct differences in disease severity and immune response patterns. Specifically, simultaneous H3N2 + HSV-1 and sequential H3N2-HSV-1 coinfections led to increased mortality, higher H3N2 viral loads, and more pronounced pulmonary inflammation. These groups exhibited elevated cytokine levels and dysregulated immune responses, with the H3N2 + HSV-1 group displaying reduced proportions of natural killer cells (NK), plasmacytoid dendritic cells (pDCs) and interferon-producing killer dendritic cells (IKDCs) in bronchoalveolar lavage fluid (BALF), while the H3N2-HSV-1 group showed a robust expansion of these innate immune cells. Additionally, these two coinfection strategies were associated with increased H3N2-specific IFN-γ⁺CD8⁺ T cells, reflecting an exacerbated adaptive response. In contrast, sequential HSV-1-H3N2 coinfection resulted in milder disease manifestations, characterized by lower mortality, decreased clinical severity, reduced cytokine levels, and diminished pro
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
63.5%
Pages per Visit
1.23
Avg Visit Duration
00:00:13
Similarity Score
100%Outbreak.info explores COVID-19 and SARS-CoV-2 data with variant surveillance reports, data on cases and deaths, and a searchable research library.
- Company
- - -
- Industry
- - -
Global Rank
#2,200,631
79,247Bounce Rate
41.2%
Pages per Visit
1.48
Avg Visit Duration
00:00:11
Similarity Score
98%department of microbiology
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
89%- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
66.22%
Pages per Visit
1.58
Avg Visit Duration
00:01:18
Similarity Score
87%The College of Natural Science privacy statement.
- Company
- - -
- Industry
- - -
Global Rank
- -
Country Rank
- -
Category Rank
- -
Bounce Rate
- -
Pages per Visit
- -
Avg Visit Duration
- -
Similarity Score
80%Born May 23, 1929, in Bucharest, Dan David endured many personal and historical tragedies before achieving freedom and success.
- Company
- - -
- Industry
- - -
Global Rank
#2,201,579
49,449Bounce Rate
36.74%
Pages per Visit
2.48
Avg Visit Duration
00:00:23
Similarity Score
74%dynavax technologies is focused on leveraging the power of the body’s innate and adaptive immune responses through toll-like receptor (tlr) stimulation.
Global Rank
#3,972,747
1,177,219Bounce Rate
39.8%
Pages per Visit
1.70
Avg Visit Duration
00:00:53
Similarity Score
71%Anivive's answers to frequently asked questions from investors
- Company
- - -
- Industry
- - -
Bounce Rate
55.08%
Pages per Visit
1.82
Avg Visit Duration
00:00:27
Similarity Score
68%VBI Vaccines Inc. (VBI) is initiating a voluntary nationwide recall of all remaining PreHevbrio® [Hepatitis B Vaccine (Recombinant); NDC 75052-001-10] (“PreHevbrio”) due to the bankruptcy of the company and termination...
- Company
- VBI Vaccines
Global Rank
#3,965,112
832,574Bounce Rate
40.52%
Pages per Visit
1.75
Avg Visit Duration
00:00:37
Similarity Score
66%At the HIRI, we do not just value excellent research. Short distances, an open door policy, and a good working atmosphere—this is what distinguishes us from others. Have a look at our current job postings.
Bounce Rate
41.13%
Pages per Visit
2.49
Avg Visit Duration
00:00:34
Similarity Score
65%gvn.org's top 5 competitors in April 2026 are: virologyj.biomedcentral.com, outbreak.info, micro.med.upenn.edu, immunobiology.arizona.edu, and more.
According to Similarweb data of monthly visits, gvn.org’s top competitor in April 2026 is virologyj.biomedcentral.com. gvn.org 2nd most similar site is outbreak.info, and closing off the top 3 is micro.med.upenn.edu.
immunobiology.arizona.edu ranks as the 4th most similar website to gvn.org and mgi.natsci.msu.edu ranks fifth in April 2026.
The other five competitors in the top 10 list are dandavidprize.org, dynavax.com, anivive.com, vbivaccines.com, and helmholtz-hiri.de.